Terms: = Brain cancer AND LDH AND Diagnosis
70 results:
1. A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan.
Wada S; Ogata D; Kashihara T; Okuma K; Eto H; Nakano E; Takahashi A; Namikawa K; Igaki H; Yamazaki N
Cancer Med; 2023 Dec; 12(24):21933-21943. PubMed ID: 38083908
[TBL] [Abstract] [Full Text] [Related]
2. Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma.
Beypınar I; Sözel Y; Önder AH
Cancer Biomark; 2023; 38(3):367-377. PubMed ID: 37718781
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes in patients with
Aglietta M; Chiarion-Sileni V; Fava P; Guidoboni M; Depenni R; Minisini A; Consoli F; Ascierto PA; Rinaldi G; Banzi M; Marconcini R; Gueli R; Ferraresi V; Tucci M; Tonini G; Lo Re G; Guida M; Del Vecchio M; Marcon IG; Queirolo P
Tumori; 2023 Dec; 109(6):537-545. PubMed ID: 37417313
[TBL] [Abstract] [Full Text] [Related]
4. RNA Sequencing in Hypoxia-Adapted T98G Glioblastoma Cells Provides Supportive Evidence for IRE1 as a Potential Therapeutic Target.
White BE; Liu Y; Hakonarson H; Buono RJ
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107600
[TBL] [Abstract] [Full Text] [Related]
5. brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
Franklin C; Mohr P; Bluhm L; Meier F; Garzarolli M; Weichenthal M; Kähler K; Grimmelmann I; Gutzmer R; Utikal J; Terheyden P; Herbst R; Haferkamp S; Pfoehler C; Forschner A; Leiter U; Ziller F; Meiss F; Ulrich J; Kreuter A; Gebhardt C; Welzel J; Schilling B; Kaatz M; Scharfetter-Kochanek K; Dippel E; Nashan D; Sachse M; Weishaupt C; Löffler H; Gambichler T; Loquai C; Heinzerling L; Grabbe S; Debus D; Schley G; Hassel JC; Weyandt G; Trommer M; Lodde G; Placke JM; Zimmer L; Livingstone E; Becker JC; Horn S; Schadendorf D; Ugurel S
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37028819
[TBL] [Abstract] [Full Text] [Related]
6. Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
Hasanov M; Milton DR; Davies AB; Sirmans E; Saberian C; Posada EL; Opusunju S; Gershenwald JE; Torres-Cabala CA; Burton EM; Colen RR; Huse JT; Glitza Oliva IC; Chung C; McAleer MF; McGovern SL; Yeboa DN; Kim BYS; Prabhu SS; McCutcheon IE; Weinberg JS; Lang FF; Tawbi HA; Li J; Haydu LE; Davies MA; Ferguson SD
Neuro Oncol; 2023 Jul; 25(7):1310-1320. PubMed ID: 36510640
[TBL] [Abstract] [Full Text] [Related]
7. Central nervous system involvement by mantle cell lymphoma.
McLaughlin N; Wang Y; Witzig T; Villasboas J; Habermann T; Inwards D; Bennani N; Thanarajasingam G; Nowakowski G; Porrata L; Thompson C; Micallef I; Johnston P; Ansell S; Paludo J
Leuk Lymphoma; 2023 Feb; 64(2):371-377. PubMed ID: 36416595
[TBL] [Abstract] [Full Text] [Related]
8. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
[TBL] [Abstract] [Full Text] [Related]
9. The sellar region as presenting theater for hematologic malignancies-A 17-year single-center experience.
Pekic S; Stojanovic M; Manojlovic Gacic E; Antic D; Milojevic T; Milicevic M; Stanimirovic A; Doknic M; Miljic D; Banjalic S; Jovanovic M; Jemuovic Z; Nikolic Djurovic M; Grujicic D; Popovic V; Petakov М
Endocr J; 2022 Sep; 69(9):1079-1090. PubMed ID: 35400679
[TBL] [Abstract] [Full Text] [Related]
10. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract] [Full Text] [Related]
11. Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.
Hilbers ML; Dimitriou F; Lau P; Bhave P; McArthur GA; Zimmer L; Kudura K; Gérard CL; Levesque MP; Michielin O; Dummer R; Cheng PF; Mangana J
Eur J Cancer; 2021 Oct; 156():149-163. PubMed ID: 34454317
[TBL] [Abstract] [Full Text] [Related]
12. Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion.
Nakamura T; Okune M; Yasuda M; Watanabe H; Ueno M; Yamaji K; Mizutani K; Kurita T; Nakazawa G
BMC Cardiovasc Disord; 2021 Jun; 21(1):272. PubMed ID: 34082695
[TBL] [Abstract] [Full Text] [Related]
13. Role of anthraquinones in Cassia occidentalis induced hepato-myo-encephalopathy.
Shukla V; Asthana S; Singh S; Anurag Tripathi
J Ethnopharmacol; 2021 Mar; 267():113431. PubMed ID: 33011371
[TBL] [Abstract] [Full Text] [Related]
14. Risk stratification of EGFR
Christopoulos P; Kirchner M; Roeper J; Saalfeld F; Janning M; Bozorgmehr F; Magios N; Kazdal D; Volckmar AL; Brückner LM; Bochtler T; Kriegsmann M; Endris V; Penzel R; Kriegsmann K; Eichhorn M; Herth FJF; Heussel CP; El Shafie RA; Schneider MA; Muley T; Meister M; Faehling M; Fischer JR; Heukamp L; Schirmacher P; Bischoff H; Wermke M; Loges S; Griesinger F; Stenzinger A; Thomas M
Lung Cancer; 2020 Oct; 148():105-112. PubMed ID: 32871455
[TBL] [Abstract] [Full Text] [Related]
15. Development, internal validation and calibration of a risk score to predict survival in patients with
Ng IK; Kumarakulasinghe NB; Syn NL; Soo RA
J Clin Pathol; 2021 Feb; 74(2):116-122. PubMed ID: 32576630
[TBL] [Abstract] [Full Text] [Related]
16. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract] [Full Text] [Related]
17. Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitors.
Hopkins AM; Kichenadasse G; McKinnon RA; Rowland A; Sorich MJ
Semin Oncol; 2019; 46(4-5):380-384. PubMed ID: 31735362
[TBL] [Abstract] [Full Text] [Related]
18. [A Case of Bone Marrow Metastasis of Oligodendroglioma with IDH Mutation and 1p/19q Codeletion].
Kiko K; Suyama K; Yamamoto K; Mochida H; Oya S; Karasawa H; Watanabe S; Suzuki Y
No Shinkei Geka; 2018 Aug; 46(8):699-706. PubMed ID: 30135292
[TBL] [Abstract] [Full Text] [Related]
19. Peritoneal Myeloid Sarcoma in a Patient Treated for a Testicular Seminoma.
Longo R; Dorvaux V; Chatelain E; Quétin P; Plastino F; Eid N; Marcon N; Hennequin L; Campitiello M
Am J Case Rep; 2018 Jun; 19():763-766. PubMed ID: 29955031
[TBL] [Abstract] [Full Text] [Related]
20. Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015.
Berthold F; Spix C; Kaatsch P; Lampert F
Paediatr Drugs; 2017 Dec; 19(6):577-593. PubMed ID: 28786082
[TBL] [Abstract] [Full Text] [Related]
[Next]
